Monday Morning Update 11/11/24 – HIStalk
Top News
Clinician network and drug marketing operator Doximity reports Q2 results: revenue up 20%, adjusted EPS $0.30 versus $0.22, beating expectations for both and sending DOCS shares up 34% in valuing the company at…
Continue Reading